Clinical Trial Update: Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 [Phase 2]

View source ↗

Summary

Phase 2 trial update for hypofractionated focal lesion ablative microboost in prostate cancer (prostate adenocarcinoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Adenocarcinoma
• Prostate Cancer
• Prostate Neoplasm

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Prostate Adenocarcinoma, Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING